LipoScience is pioneering a new field of personalized diagnostics based on nuclear magnetic resonance (NMR) technology.
LipoScience is pioneering a new field of personalized diagnostics based on nuclear magnetic resonance (NMR) technology. Its first proprietary diagnostic test, the NMR LipoProfile® test, measures the number of low density lipoprotein particles (LDL-P) in a blood sample and provides physicians and their patients with actionable information to personalize management of risk for heart disease. To date, over 8 million NMR LipoProfile tests have been ordered.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Aug 15, 2006 | Series F | $13M | 1 | — | — | Detail |
Aug 7, 2003 | Series E | $15M | 1 | — | — | Detail |